Efficacy and safety of topical WBI-1001 in patients with mild to severe atopic dermatitis: results from a 12-week, multicentre, randomized, placebo-controlled double-blind trial.

Saved in:
Bibliographic Details
Title: Efficacy and safety of topical WBI-1001 in patients with mild to severe atopic dermatitis: results from a 12-week, multicentre, randomized, placebo-controlled double-blind trial.
Authors: Bissonnette, R.1, Poulin, Y.2, Zhou, Y.3, Tan, J.4, Hong, H.C.5, Webster, J.6, Ip, W.6, Tang, L.6, Lyle, M.6
Source: British Journal of Dermatology. Apr2012, Vol. 166 Issue 4, p853-860. 8p.
Database: Academic Search Ultimate
Be the first to leave a comment!
You must be logged in first